ENDEFR
Home › Spain › TOWA PHARMA INTERNATIONAL HOLDINGS S.L. (SOCIEDAD UNIPERSONAL)

TOWA PHARMA INTERNATIONAL HOLDINGS S.L. (SOCIEDAD UNIPERSONAL)

Sociedad Limitada Unipersonal (SLU) · Martorelles, Spain · LEI 959800CV21V16FBH1P75
LEI active

Summary

TOWA PHARMA INTERNATIONAL HOLDINGS S.L. (SOCIEDAD UNIPERSONAL) is registered in Spain and entered in the “Commercial Registry (Registro Mercantil)” under number 1000378535165. Its legal form is Sociedad Limitada Unipersonal (SLU) – single-member limited company (Spain). According to GLEIF, its ultimate parent is 東和薬品株式会社 (Japan), which is also its direct parent. That group has 3 subsidiaries with LEIs in 2 countries, 3 of them in Spain. It has 2 direct subsidiaries in GLEIF data. The LEI was first issued on 29 Oct 2020 and the record was last updated on 16 Aug 2026; the next renewal is due by 7 Feb 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formSociedad Limitada Unipersonal (SLU)
single-member limited company (Spain)
RegisterCommercial Registry (Registro Mercantil) · Register website
Registration number1000378535165
Registration authorityRegistrars of Spain
JurisdictionSpain
Registered addressCALLE DE SANT MARTI 75 bloque d, 08107 Martorelles, Spain
Headquarters addressCALLE DE SANT MARTI 75 BLOQUE D, 08107 Martorelles, Spain
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)20 Dec 2019
LEI959800CV21V16FBH1P75
LEI statusactive
LEI first issued29 Oct 2020
LEI record last updated16 Aug 2026
Next LEI renewal7 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

東和薬品株式会社 Japan ultimate parent
TOWA PHARMA INTERNATIONAL HOLDINGS S.L. (SOCIEDAD UNIPERSONAL) this entity
TOWA PHARMACEUTICAL EUROPE S.L. (SOCIEDAD UNIPERSONAL) Spain
TOWA PHARMACEUTICAL S.A. Spain
View the whole group: 3 subsidiaries in 2 countries

Relationship to the parent

Direct parentUltimate parent
Parent東和薬品株式会社東和薬品株式会社
Accounting period1 Apr 2024 to 31 Mar 20251 Apr 2024 to 31 Mar 2025
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Relationship start5 Oct 20205 Oct 2020
Recorded at GLEIF since29 Oct 202029 Oct 2020
Last updated16 Aug 202616 Aug 2026
Record statuscurrentcurrent

Direct subsidiaries (2)